Treating Wilms Tumor with vincristine and irinotecan | Children's National

Treating Wilms Tumor with vincristine and irinotecan | Children's National

Study looks at treating Wilms Tumor with vincristine and irinotecan A study led by Jeffrey S. Dome, M.D, Ph.D., tested the anti-tumor activity of the chemotherapy combination vincristine and irinotecan in patients with metastatic diffuse anaplastic Wilms tumor. The results showed that the vincristine/irinotecan combination is highly active. Of the patients who received this combination, 78% had an objective tumor response.